Immunological characteristics of diabetes in schizophrenia.
Cohen
Dan
D
Batstra
M R
MR
Gispen-de Wied
C C
CC
D014150:Antipsychotic Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood; D002746:Chlorpromazine / Q000627:therapeutic use; D048909:Diabetes Complications / Q000276:immunology*; D003920:Diabetes Mellitus / Q000276:immunology*; D006801:Humans; D007330:Insulin Antibodies / Q000097:blood; D012016:Reference Values; D012559:Schizophrenia / Q000150:complications* / Q000276:immunology*
D014150:Antipsychotic Agents; D001323:Autoantibodies; D007330:Insulin Antibodies; D002746:Chlorpromazine